Vit D Tasso+
DeviceBlood collected using Tasso device
NCT Number: NCT07782528
This study will evaluate the performance and acceptability of different sampling methods for measuring vitamin D, specifically 25-hydroxyvitamin D₂ and 25-hydroxyvitamin D₃.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
This study will evaluate the performance and acceptability of different sampling methods for measuring vitamin D, specifically 25-hydroxyvitamin D₂ and 25-hydroxyvitamin D₃. It will compare results obtained from the routine self-collected dried blood spot (DBS) cards currently in use in our laboratory, with paired capillary and venous serum samples. This compares the collection using three approaches: finger-prick DBS, venepuncture, and the CE-marked Tasso+ upper-arm self-sampling device. The study aims to assess both quantitative agreement between sample types and user acceptability of each collection method.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Blood collected using Tasso device
Time frame: From Study start date for up to 12 months
Continuous 25(OH)D₂ and 25(OH)D₃ concentrations (nmol/L)
Time frame: From Study start date for up to 12 months
Pain, on a scale from 1-5
1= no pain. 5= worse pain
Time frame: From study start date to 12 months
Ease of Use: how easy or difficult each method was to complete
1= Very difficult, 5=Very easy
Dried Bloodspot Venepuncture Tasso+
Time frame: From Study start date for up to 12 months
Clarity of Instructions: how clear were the instructions you were given?
1= Not clear at all, 5=Extremely clear
Dried Bloodspot Venepuncture Tasso+
Time frame: From Study start date for up to 12 months
Safety: How safe did each method feel to you ?
1= Very unsafe, 5=Very safe
Dried Bloodspot Venepuncture Tasso+
Time frame: From Study start date for up to 12 months
Your Preference: please rank the three collection methods
1= your favourite, 3=least preferred
Dried Bloodspot Venepuncture Tasso+
Time frame: From Study start date for up to 12 months
Willingness to self-collect: how willing would you be to collect your own sample using each method in the future?
1= Very willing, 5=Very willing
Dried Bloodspot Venepuncture Tasso+
Time frame: From Study start date for up to 12 months
Volume adequacy- minimum blood vol 200uL
Time frame: From Study start date for up to 12 months
Pre analytical failure- % samples unacceptable for analysis due to inadequate volume or poor quality blood spot
Time frame: From Study start date for up to 12 months
Hands on time (hrs/mins)
Time frame: From Study start date for up to 12 months
Batch failures based on LCMSMS batch acceptance criteria- QC with +/- 2sd of mean, cal curve R value > 0.95
Time frame: From Study start date for up to 12 months
Repeat samples (%)
Time frame: From Study start date for up to 12 months
Time from sample request to result authorisation
Time frame: From Study start date for up to 12 months
Numerical agreement (statistically quantified by Passing and Bablok analysis)
Time frame: From Study start date for up to 12 months
Vitamin D status category agreement (deficient / insufficient / replete) quantified statistically using Cohen's kappa analysis
The Royal Wolverhampton Hospitals NHS Trust
Other Gov
Evaluation of a Capillary Self-sampling Device for Vitamin D Testing
Acronym: VitD TASSO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07127796
Dietary Supplement, Vitamin D
View Trial DetailsNCT07341308
Metabolism Changes, Vitamin D
Fort Collins, Colorado, United States
View Trial DetailsNCT07673497
Colitis, Colitis, Ulcerative
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial DetailsNCT02361827
In Vitro Fertilization, Ongoing Pregnancy Rate
Zhengzhou, Henan, China
View Trial Details